Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCA HSVtK (#RDB01427)

pCAcctk Herpes simplex virus-tk gene expression

Alternative name pCAcctk
Clone info. Expression vector of simplex herpes virus tk gene in ammalian cells
Vector backbone pCAGGS (Plasmid)
Size of vector backbone 4.8 kb
Selectable markers Amp^r (E. coli)
Gene/insert name HSV thymidine kinase Genomic DNA
Depositor|Developer Hamada, Hirofumi |
 
Additional map

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) and an acknowledgment to Dr. Jun-ich Miyazaki of the Osaka University are requested.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。
MTAに書く付加的使用条件:
CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用し、大阪大学 宮崎純一博士への謝辞の表明を必要とする。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB01427 pCA HSVtK DNA solution Please contact us.

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCA HSVtK was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01427).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB16749_A8Jcp1-2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CAG_R1 (Pr0584)
Region: CAC pro,insert 5'(HSV TK 5'-UTR,HSV TK CDS 5')
Sequence file: RDB16749_A8Jce.seq check
>01427_16749_A8Jc_CAG_R1_C02_08_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNNNC CNTCNAGCGG GCGCGGGGCG AAGCGGTGCG GCGCCGGCAG
   61 GAAGGAAATG GGCGGGGAGG GCCTTCGTGC GTCGCCGCGC CGCCGTCCCC TTCTCCCTCT
  121 CCAGCCTCGG GGCTGTCCGC GGGGGGACGG CTGCCTTCGG GGGGGACGGG GCAGGGCGGG
  181 GTTCGGCTTC TGGCGTGTGA CCGGCGGCTC TAGAGCCTCT GCTAACCATG TTCATGCCTT
  241 CTTCTTTTTC CTACAGCTCC TGGGCAACGT GCTGGTTATT GTGCTGTCTC ATCATTTTGG
  301 CAAAGAATTG ATCTTGGTGG CGTGAAACTC CCGCACCTCT TCGGCAAGCG CCTTGTAGAA
  361 GCGCGTATGG CTTCGTACCC CTGCCATCAA CACGCGTCTG CGTTCGACCA GGCTGCGCGT
  421 TCTCGCGGCC ATAGCAACCG ACGTACGGCG TTGCGCCCTC GCCGGCAGCA AGAAGCCACG
  481 GAAGTCCGCC TGGAGCAGAA AATGCCCACG CTACTGCGGG TTTATATAGA CGGTCCTCAC
  541 GGGATGGGGA AAACCACCAC CACGCAACTG CTGGTGGCCC TGGGTTCGCG CGACGATATC
  601 GTCTACGTAC CCGAGCCGAT GACTTACTGG CAGGTGCTGG GGGCTTCCGA GACAATCGCG
  661 AACATCTACA CCACACAACA CCGCCTCGAC CAGGGTGAGA TATCGGCCGG GGACGCGGCG
  721 GTGGTAATGA CAAGCGCCCA GATAACAATG GGCATGCCTT ATGCCGTGAC CGACGCCGTT
  781 CTGGCTCCTC ATATCGGGGG GGANGCTGGG AGCTCACATG CCCCGCCCCC GGCCNNCACC
  841 CTCATCTTCN ANCGCCATCC CATCGCCGCC CTCCNGTGCT ACNCGGCCGC GCGATACCTT
  901 ATGGGCAGCA TGNNCCCCCC AGGCCGNGCT GGCGTTCGNN GCCNTNATCC CNCCNANCTT
  961 GCCCNGNNNC AAANNTCNNN TNGGGGGGNC NNTNCNGANN NNANNNACAT NNNNNNNNNN
//
Primer: pCAGGS_R1 (Pr0614)
Region: bgh pA,insert 3'(HSV genome seq)
Sequence file: RDB16749_A8Jcf.seq check
>01427_16749_A8Jc_pCAGGS_R1_D02_11_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNCNC TNNNGNNNTG AAANTAAATT TCCTTTATTA GCCAGAAGTC
   61 AGATGCTCAA GGGGCTTCAT GATGTCCCCA TAATTTTTGG CAGAGGGAAA AAGATCTCAG
  121 TGGTATTTGT GAGCCAGGGC ATTGGCCACA CCAGCCACCA CCTTCTGATA GGCAGCCTGC
  181 ACCTGAGGAG TGAATTGATC TATAGATCAT GAGTGGGAGG AATGAGCTGG CCCTTAATTT
  241 GGTTTTGCTT GTTTAAATTA TGATATCCAA CTATGAAACA TTATCATAAA GCAATAGTAA
  301 AGAGCCTTCA GTAAAGAGCA GGCATTTATC TAATCCCACC CCACCCCCAC CCCCGTAGCT
  361 CCAATCCTTC CATTCAAAAT GTAGGTACTC TGTTCTCACC CTTCTTAACA AAGTATGACA
  421 GGAAAAACTT CCATTTTAGT GGACATCTTT ATTGTTTAAT AGATCATCAA TTTCTGCAGG
  481 TCCTGGCCGG GGTCCCGCGG AAACTCGGCC GTGGTGACCA ATACAAAACA AAAGCGCTCC
  541 TCGTACCAGC GAAGAAGGGG CAGAGATGCC GTAGTCAGGT TTAGTTCGTC CGGCGGCGCC
  601 AGAAATCCGC GCGGTGGTTT TTGGGGGTCG GGGGTGTTTG GCAGCCACAG ACGCCCGGTG
  661 TTCGTGTCGC GCCAGTACAT GCGGTCCATG CCCAGGCCAT CCAAAAACCA TGGGTCTGTC
  721 TGCTCAGTCC AGTCGTGGAN CTGNCCCCAC GCAACGCCCA AAATAATAAC CCCCACGAAC
  781 CATAAACCAT TCCCCATGGG GGANCCCGTC CCTAACCCAC GGGGCCNGTG GCTATGGCAG
  841 GGCTTGCCGC CCCGACGTTG GCTGCGAGCC CTNGGCCTTC ACCCGAACTT GGGGGGNGGG
  901 GNGGGGAAAA GGAANAAACG CGGGCGTATT GGCCCCNATG GGGNCNCNGN GNNNATCGNN
  961 ANAGTGCCAG CCCTGGGNNC GANNCCNNNN TTTATGNNNN ANNNANCCNN CNCCCNNNNN
1021 NTNTNNNNNN NNNTTTNNNN NNNNNN
//
Primer: HSVTKup_f (Pr0736)
Region: insert mid(HSV TK CDS 3')
Sequence file: RDB16749_A8Jcg.seq check
>01427_16749_B2L7F_HSVTKup_F_B01_02_ABI08.ab1
    1 NNNNNNNNNN TTTNNNNNNN NNTTTTATTG CCNNCATAGC GCGGGTTCCT TCCGGTATTG
   61 TCTCCTTCCG TGTTTCAGTT AGCCTCCCCC ATCTCCCGGG CAAACGTGCG CGCCAGGTCG
  121 CAGATCGTCG GTATGGAGCC GGGGGTGGTG ACGTGGGTCT GGACCATCCC GGAGGTAAGT
  181 TGCAGCAGGG CGTCCCGGCA GCCGGCGGGC GATTGGTCGT AATCCAGGAT AAAGACGTGC
  241 ATGGGACGGA GGCGTTTGGC CAAGACGTCC AAGGCCCAGG CAAACACGTT GTACAGGTCG
  301 CCGTTGGGGG CCAGCAACTC GGGGGCCCGA AACAGGGTAA ATAACGTGTC CCCGATATGG
  361 GGTCGTGGGC CCGCGTTGCT CTGGGGCTCG GCACCCTGGG GCGGCACGGC CGTCCCCGAA
  421 AGCTGTCCCC AATCCTCCCG CCACGACCCG CCGCCCTGCA GATACCGCAC CGTATTGGCA
  481 AGCAGCCCGT AAACGCGGCG AATCGCGGCC AGCATAGCCA GGTCAAGCCG CTCGCCGGGG
  541 CGCTGGCGTT TGGCCAGGCG GTCGATGTGT CTGTCCTCCG GAANGNNNNC CAACACGATG
  601 TTTGTGCCGG GCAAGGTCGG CGGGATGAGG GCCACNAACG CCANNNNNGC CTGNGGGGTC
  661 NNNNNNCCCA TAANGTATCG CGCGGCCGGG TAGCACAGGA NGGCGGCGAT NNNATGNNNG
  721 TCGAANANGA NGNTGAGGNC CNGGGGGCNN NGCATGTGAN NTNNCANCCT CCNNCCNNNN
781 ANATNANNAG CCNNAANNNN NNNNNN
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles